ArticleJAMA dermatology2023

Assessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.

Dayan J Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.